Dermata Therapeutics, Inc. announced the appointment of Brittany Bradrick to its Board of Directors and its Audit Committee. Ms. Bradrick has served as the Chief Financial Officer of Neurelis, Inc. since October 2021. Upon her appointment to the Board of Directors, Ms. Bradrick will join the Audit Committee of Dermata, replacing Dr. Steven Mento.

Ms. Bradrick was selected as a director due to her extensive industry and financial experience. Dr. Mento will continue to serve as a director at Dermata, including participation on the Nominating and Corporate Governance Committee.